|
1
|
Radiofrequency ablation in Barrett's esophagus with dysplasia.
|
N Engl J Med
|
2009
|
10.91
|
|
2
|
Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial.
|
Gastrointest Endosc
|
2005
|
4.78
|
|
3
|
Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients.
|
Gastrointest Endosc
|
2007
|
3.53
|
|
4
|
Durability of radiofrequency ablation in Barrett's esophagus with dysplasia.
|
Gastroenterology
|
2011
|
3.44
|
|
5
|
Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia.
|
Gastrointest Endosc
|
2007
|
3.23
|
|
6
|
Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus.
|
Gastroenterology
|
2002
|
2.88
|
|
7
|
Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus.
|
Gastroenterology
|
2007
|
2.86
|
|
8
|
Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up.
|
Gastrointest Endosc
|
2008
|
2.51
|
|
9
|
Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia.
|
Gastrointest Endosc
|
2010
|
2.28
|
|
10
|
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.
|
Clin Cancer Res
|
2006
|
2.24
|
|
11
|
The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study.
|
J Natl Cancer Inst
|
2002
|
2.13
|
|
12
|
Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk.
|
Cancer Prev Res (Phila)
|
2008
|
2.11
|
|
13
|
Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus.
|
Gastrointest Endosc
|
2007
|
2.06
|
|
14
|
History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.
|
Gastroenterology
|
2010
|
2.05
|
|
15
|
The crosstalk of mTOR/S6K1 and Hedgehog pathways.
|
Cancer Cell
|
2012
|
2.02
|
|
16
|
Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium.
|
Gastroenterology
|
2013
|
1.92
|
|
17
|
Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus.
|
Gastroenterology
|
2009
|
1.88
|
|
18
|
Utility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus.
|
Gastroenterology
|
2008
|
1.87
|
|
19
|
Age-related changes in the pancreas identified by EUS: a prospective evaluation.
|
Gastrointest Endosc
|
2005
|
1.86
|
|
20
|
Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus.
|
Clin Gastroenterol Hepatol
|
2003
|
1.82
|
|
21
|
Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: a multicenter study.
|
Gastrointest Endosc
|
2011
|
1.82
|
|
22
|
Depth of submucosal invasion does not predict lymph node metastasis and survival of patients with esophageal carcinoma.
|
Clin Gastroenterol Hepatol
|
2009
|
1.74
|
|
23
|
Prevalence and predictors of recurrent neoplasia after ablation of Barrett's esophagus.
|
Gastrointest Endosc
|
2009
|
1.66
|
|
24
|
A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus.
|
Cancer Res
|
2009
|
1.65
|
|
25
|
Initial evaluation of the efficacy and safety of endoscopic ultrasound-guided direct Ganglia neurolysis and block.
|
Am J Gastroenterol
|
2007
|
1.58
|
|
26
|
Prospective assessment of EUS criteria for lymphadenopathy associated with rectal cancer.
|
Gastrointest Endosc
|
2008
|
1.55
|
|
27
|
Endoscopic tri-modal imaging is more effective than standard endoscopy in identifying early-stage neoplasia in Barrett's esophagus.
|
Gastroenterology
|
2010
|
1.47
|
|
28
|
Biomarkers in gastrointestinal cancers.
|
Am J Gastroenterol
|
2008
|
1.45
|
|
29
|
Comparison of methods to detect neoplasia in patients undergoing endoscopic ultrasound-guided fine-needle aspiration.
|
Gastroenterology
|
2012
|
1.43
|
|
30
|
MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma.
|
Clin Cancer Res
|
2009
|
1.35
|
|
31
|
Predictors of progression in Barrett's esophagus: current knowledge and future directions.
|
Am J Gastroenterol
|
2010
|
1.35
|
|
32
|
Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells.
|
Gastroenterology
|
2007
|
1.34
|
|
33
|
Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome.
|
PLoS One
|
2010
|
1.33
|
|
34
|
Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study.
|
Am J Gastroenterol
|
2011
|
1.32
|
|
35
|
Utility of endoscopic ultrasound in the diagnosis of aberrant right subclavian artery.
|
J Gastroenterol Hepatol
|
2007
|
1.27
|
|
36
|
The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on imaging in Barrett's Esophagus.
|
Gastrointest Endosc
|
2012
|
1.23
|
|
37
|
Safety of prior endoscopic mucosal resection in patients receiving radiofrequency ablation of Barrett's esophagus.
|
Clin Gastroenterol Hepatol
|
2011
|
1.22
|
|
38
|
Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus.
|
Am J Gastroenterol
|
2007
|
1.20
|
|
39
|
MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma.
|
Cancer Prev Res (Phila)
|
2013
|
1.18
|
|
40
|
EUS-FNA assessment of extramesenteric lymph node status in primary rectal cancer.
|
Gastrointest Endosc
|
2011
|
1.17
|
|
41
|
Endoscopic ultrasound-guided trucut biopsy of the cyst wall for diagnosing cystic pancreatic tumors.
|
Clin Gastroenterol Hepatol
|
2005
|
1.16
|
|
42
|
Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
|
Cancer Res
|
2008
|
1.15
|
|
43
|
Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysis.
|
Cancer Prev Res (Phila)
|
2010
|
1.12
|
|
44
|
A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett's esophagus.
|
Hum Pathol
|
2008
|
1.12
|
|
45
|
Frozen section analysis of esophageal endoscopic mucosal resection specimens in the real-time management of Barrett's esophagus.
|
Clin Gastroenterol Hepatol
|
2006
|
1.12
|
|
46
|
Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features.
|
PLoS One
|
2008
|
1.12
|
|
47
|
Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma.
|
J Gastroenterol Hepatol
|
2005
|
1.10
|
|
48
|
The development of a fluorescence in situ hybridization assay for the detection of dysplasia and adenocarcinoma in Barrett's esophagus.
|
J Mol Diagn
|
2006
|
1.09
|
|
49
|
False positive endoscopic ultrasound fine needle aspiration cytology: incidence and risk factors.
|
Gut
|
2010
|
1.09
|
|
50
|
Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.08
|
|
51
|
Diagnostic performance of two confocal endomicroscopy systems in detecting Barrett's dysplasia: a pilot study using a novel bioprobe in ex vivo tissue.
|
Gastrointest Endosc
|
2012
|
1.08
|
|
52
|
EMR for early stage esophageal cancer: setting the stage for improved patient outcomes.
|
Gastrointest Endosc
|
2003
|
1.07
|
|
53
|
Biopsy depth after radiofrequency ablation of dysplastic Barrett's esophagus.
|
Gastrointest Endosc
|
2010
|
1.03
|
|
54
|
Distinct role of Kruppel-like factor 11 in the regulation of prostaglandin E2 biosynthesis.
|
J Biol Chem
|
2010
|
1.02
|
|
55
|
Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for barrett esophagus: implications for staging of adenocarcinoma.
|
Am J Surg Pathol
|
2008
|
1.00
|
|
56
|
Metabolic syndrome as a risk factor for Barrett esophagus: a population-based case-control study.
|
Mayo Clin Proc
|
2013
|
0.99
|
|
57
|
Adequacy of endoscopic ultrasound core needle biopsy specimen of nonmalignant hepatic parenchymal disease.
|
Clin Gastroenterol Hepatol
|
2008
|
0.98
|
|
58
|
Successful endoscopic treatment of intraductal extension of a villous adenoma with high-grade dysplasia, with 3-year follow-up.
|
Gastrointest Endosc
|
2011
|
0.96
|
|
59
|
A comparative analysis by SAGE of gene expression profiles of Barrett's esophagus, normal squamous esophagus, and gastric cardia.
|
Gastroenterology
|
2005
|
0.96
|
|
60
|
Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia.
|
Gastroenterology
|
2008
|
0.95
|
|
61
|
Efficient automated assessment of genetic abnormalities detected by fluorescence in situ hybridization on brush cytology in a Barrett esophagus surveillance population.
|
Cancer
|
2007
|
0.94
|
|
62
|
Barrett esophagus: an update.
|
Nat Rev Gastroenterol Hepatol
|
2010
|
0.92
|
|
63
|
Secondary linitis plastica of the rectum: EUS features and tissue diagnosis (with video).
|
Gastrointest Endosc
|
2008
|
0.92
|
|
64
|
Mechanisms of disease: Carcinogenesis in Barrett's esophagus.
|
Nat Clin Pract Gastroenterol Hepatol
|
2004
|
0.91
|
|
65
|
Isolation and sequencing of a novel tropomyosin isoform preferentially associated with colon cancer.
|
Gastroenterology
|
2002
|
0.91
|
|
66
|
Photodynamic therapy for unresectable cholangiocarcinoma: a comparative effectiveness systematic review and meta-analyses.
|
Photodiagnosis Photodyn Ther
|
2012
|
0.89
|
|
67
|
Prospective cytological assessment of gastrointestinal luminal fluid acquired during EUS: a potential source of false-positive FNA and needle tract seeding.
|
Am J Gastroenterol
|
2010
|
0.89
|
|
68
|
Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma.
|
Clin Gastroenterol Hepatol
|
2007
|
0.88
|
|
69
|
Prospective study of bacteremia and complications With EUS FNA of rectal and perirectal lesions.
|
Clin Gastroenterol Hepatol
|
2007
|
0.88
|
|
70
|
Endoscopic mucosal resection in the management of esophageal neoplasia: current status and future directions.
|
Clin Gastroenterol Hepatol
|
2010
|
0.87
|
|
71
|
Fluorescence in situ hybridization mapping of esophagectomy specimens from patients with Barrett's esophagus with high-grade dysplasia or adenocarcinoma.
|
Hum Pathol
|
2011
|
0.86
|
|
72
|
Preoperative diagnosis of extrapancreatic neural invasion in pancreatic cancer.
|
Clin Gastroenterol Hepatol
|
2006
|
0.86
|
|
73
|
Epithelial mesenchymal transition and cancer stem cells in esophageal adenocarcinoma originating from Barrett's esophagus.
|
Oncol Lett
|
2012
|
0.86
|
|
74
|
Correlation of histology with biomarker status after photodynamic therapy in Barrett esophagus.
|
Cancer
|
2008
|
0.86
|
|
75
|
Population screening for barrett esophagus: a prospective randomized pilot study.
|
Mayo Clin Proc
|
2011
|
0.85
|
|
76
|
Safety of endoscopic mucosal resection for Barrett's esophagus.
|
Am J Gastroenterol
|
2013
|
0.85
|
|
77
|
Inhibition of Notch signaling enhances transdifferentiation of the esophageal squamous epithelium towards a Barrett's-like metaplasia via KLF4.
|
Cell Cycle
|
2014
|
0.83
|
|
78
|
Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma.
|
Carcinogenesis
|
2013
|
0.83
|
|
79
|
Outcomes of T1b esophageal adenocarcinoma patients.
|
Gastrointest Endosc
|
2011
|
0.82
|
|
80
|
Preliminary experience comparing routine cytology results with the composite results of digital image analysis and fluorescence in situ hybridization in patients undergoing EUS-guided FNA.
|
Gastrointest Endosc
|
2007
|
0.82
|
|
81
|
Barrett's esophagus in 2012: updates in pathogenesis, treatment, and surveillance.
|
Curr Gastroenterol Rep
|
2013
|
0.82
|
|
82
|
Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma.
|
Inflamm Bowel Dis
|
2013
|
0.82
|
|
83
|
Utility of baseline positron emission tomography with computed tomography for predicting endoscopic resectability and survival outcomes in patients with early esophageal adenocarcinoma.
|
J Gastroenterol Hepatol
|
2013
|
0.81
|
|
84
|
Endocytoscopy in esophageal cancer.
|
Gastrointest Endosc Clin N Am
|
2009
|
0.80
|
|
85
|
Prevalence of esophageal eosinophils in patients with Barrett's esophagus.
|
Am J Gastroenterol
|
2011
|
0.80
|
|
86
|
Allelic imbalance of 7q32.3-q36.1 during tumorigenesis in Barrett's esophagus.
|
Cancer Res
|
2002
|
0.80
|
|
87
|
Endoscopic therapy for Barrett's esophagus and early esophageal adenocarcinoma.
|
Gastroenterol Clin North Am
|
2013
|
0.79
|
|
88
|
Local recurrence detection following transanal excision facilitated by EUS-FNA.
|
Hepatogastroenterology
|
2012
|
0.79
|
|
89
|
Role of mucosal ablative therapy in the treatment of the columnar-lined esophagus.
|
Chest Surg Clin N Am
|
2002
|
0.79
|
|
90
|
Ablation is in the eye of the beholder.
|
Clin Gastroenterol Hepatol
|
2013
|
0.79
|
|
91
|
Screening, surveillance, and prevention for esophageal cancer.
|
Gastroenterol Clin North Am
|
2009
|
0.79
|
|
92
|
A new era: endoscopic tissue transplantation.
|
Curr Opin Gastroenterol
|
2013
|
0.77
|
|
93
|
Tissue-engineered cell sheets for stricture prevention: a new connection between endoscopy and regenerative medicine.
|
Gastroenterology
|
2012
|
0.77
|
|
94
|
Endoscopy: NBI in Barrett esophagus--look more and sample less.
|
Nat Rev Gastroenterol Hepatol
|
2012
|
0.77
|
|
95
|
Double trouble: two cases of squamous carcinoma arising from Barrett's dysplasia after endoscopic mucosal resection.
|
Am J Gastroenterol
|
2012
|
0.77
|
|
96
|
Changes in screening, prognosis and therapy for esophageal adenocarcinoma in Barrett's esophagus.
|
Curr Opin Gastroenterol
|
2009
|
0.76
|
|
97
|
Endpoints for radiofrequency ablation in Barrett's dysplasia.
|
Am J Gastroenterol
|
2013
|
0.76
|
|
98
|
The role of cellular senescence in the gastrointestinal mucosa.
|
Gut Liver
|
2013
|
0.76
|
|
99
|
Selecting treatment for Barrett's esophagus: no second chances to make a first impression.
|
Clin Gastroenterol Hepatol
|
2008
|
0.76
|
|
100
|
Rodent endosonography to monitor esophageal cancer.
|
Int J Gastrointest Cancer
|
2006
|
0.76
|
|
101
|
Nonsurgical management of Barrett's esophagus with high-grade dysplasia.
|
Surg Oncol Clin N Am
|
2002
|
0.76
|
|
102
|
Endoscopic Mucosal Resection: Esophageal Applications.
|
Curr Treat Options Gastroenterol
|
2005
|
0.76
|
|
103
|
Advanced imaging in GI mucosal disease: do you see what I see?
|
Gastrointest Endosc
|
2011
|
0.76
|
|
104
|
Endoscopic-ultrasound-guided tissue sampling facilitates the detection of local recurrence and extra pelvic metastasis in pelvic urologic malignancy.
|
Diagn Ther Endosc
|
2012
|
0.75
|
|
105
|
Endoscopic confocal microscopy: imaging to facilitate the dawn of endoluminal surgery.
|
Clin Gastroenterol Hepatol
|
2007
|
0.75
|
|
106
|
Synergistic effects of photodynamic therapy with HPPH and gemcitabine in pancreatic cancer cell lines.
|
Lasers Surg Med
|
2012
|
0.75
|
|
107
|
Toupet or not Toupet, that is the question.
|
J Clin Gastroenterol
|
2002
|
0.75
|
|
108
|
The wizards of odds: cost-effectiveness, Barrett's screening, and surveillance guidelines.
|
Clin Gastroenterol Hepatol
|
2004
|
0.75
|
|
109
|
Changing faces of Barrett's esophagus: implications for adenocarcinoma.
|
Gastroenterology
|
2010
|
0.75
|
|
110
|
Prediction of Progression in Barrett's Esophagus Using a Tissue Systems Pathology Test: A Pooled Analysis of International Multicenter Studies.
|
Clin Gastroenterol Hepatol
|
2022
|
0.75
|
|
111
|
Management of Barrett's esophagus with high-grade dysplasia.
|
Surg Clin North Am
|
2002
|
0.75
|
|
112
|
Endoscopic therapy in patients with Barrett's esophagus and portal hypertension.
|
Gastrointest Endosc
|
2007
|
0.75
|
|
113
|
Simulation Research in Gastrointestinal and Urologic Care-Challenges and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases and National Institute of Biomedical Imaging and Bioengineering Workshop.
|
Ann Surg
|
2017
|
0.75
|
|
114
|
Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.
|
Am J Surg Pathol
|
2008
|
0.75
|
|
115
|
Enhanced endoscopic imaging. Preface.
|
Gastrointest Endosc Clin N Am
|
2009
|
0.75
|
|
116
|
Optical detection and eradication of dysplastic Barrett's esophagus.
|
Technol Cancer Res Treat
|
2003
|
0.75
|
|
117
|
Barrett's esophagus: pathogenesis, treatment, and prevention.
|
Gastrointest Endosc Clin N Am
|
2008
|
0.75
|
|
118
|
A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumors.
|
Invest New Drugs
|
2010
|
0.75
|
|
119
|
Knowledge of indications for EUS among gastroenterologists and non-gastroenterologists.
|
Gastrointest Endosc
|
2004
|
0.75
|
|
120
|
Letter from the editors.
|
Dis Esophagus
|
2005
|
0.75
|
|
121
|
Electronic images of the month. Large refractory sporadic gastric fundic gland polyp with low-grade dysplasia.
|
Clin Gastroenterol Hepatol
|
2010
|
0.75
|
|
122
|
A moveable feast.
|
Clin Gastroenterol Hepatol
|
2007
|
0.75
|
|
123
|
Simulation Research in Gastrointestinal and Urologic Care-Challenges and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases and National Institute of Biomedical Imaging and Bioengineering Workshop.
|
J Clin Gastroenterol
|
2017
|
0.75
|